F. Le Coz

576 total citations
23 papers, 468 citations indexed

About

F. Le Coz is a scholar working on Cognitive Neuroscience, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, F. Le Coz has authored 23 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cognitive Neuroscience, 7 papers in Pharmacology and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in F. Le Coz's work include Sleep and related disorders (4 papers), Memory and Neural Mechanisms (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). F. Le Coz is often cited by papers focused on Sleep and related disorders (4 papers), Memory and Neural Mechanisms (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). F. Le Coz collaborates with scholars based in France, Switzerland and Italy. F. Le Coz's co-authors include H. Allain, Patrice Jaillon, Christian Funck‐Brentano, Alain Patat, J.M. Gandon, Alain Lieury, J.‐M. POIRIER, Mathieu Ghadanfar, Audrey Mallet and Virginia Parks and has published in prestigious journals such as Circulation, SLEEP and Psychopharmacology.

In The Last Decade

F. Le Coz

23 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Le Coz France 14 149 93 87 81 76 23 468
C. Dubruc France 17 50 0.3× 103 1.1× 117 1.3× 84 1.0× 75 1.0× 38 670
O Varoquaux France 12 38 0.3× 87 0.9× 19 0.2× 83 1.0× 17 0.2× 23 393
M Maggini Italy 7 34 0.2× 99 1.1× 49 0.6× 52 0.6× 16 0.2× 14 385
Hidenobu Suzuki Japan 14 39 0.3× 44 0.5× 39 0.4× 70 0.9× 20 0.3× 39 441
Taneem Amin United States 9 45 0.3× 76 0.8× 101 1.2× 119 1.5× 10 0.1× 10 413
Ulrike Ebert Germany 11 27 0.2× 74 0.8× 91 1.0× 67 0.8× 12 0.2× 20 532
Eric Legangneux Switzerland 14 23 0.2× 86 0.9× 163 1.9× 179 2.2× 118 1.6× 29 581
R E Newton United States 9 16 0.1× 121 1.3× 48 0.6× 56 0.7× 32 0.4× 12 407
Jill Goddard United States 10 18 0.1× 209 2.2× 55 0.6× 134 1.7× 74 1.0× 11 574
Michael Desch Germany 13 107 0.7× 76 0.8× 30 0.3× 255 3.1× 9 0.1× 20 503

Countries citing papers authored by F. Le Coz

Since Specialization
Citations

This map shows the geographic impact of F. Le Coz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Le Coz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Le Coz more than expected).

Fields of papers citing papers by F. Le Coz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Le Coz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Le Coz. The network helps show where F. Le Coz may publish in the future.

Co-authorship network of co-authors of F. Le Coz

This figure shows the co-authorship network connecting the top 25 collaborators of F. Le Coz. A scholar is included among the top collaborators of F. Le Coz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Le Coz. F. Le Coz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacquemin, Emmanuel, B. Hermeziu, F. Le Coz, et al.. (2009). Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis. Journal of Clinical Pharmacy and Therapeutics. 34(5). 515–522. 28 indexed citations
2.
Patat, Alain, Virginia Parks, Sangeeta Raje, et al.. (2009). Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects. British Journal of Clinical Pharmacology. 67(3). 299–308. 17 indexed citations
3.
Bourrinet, Philippe, Eric Martel, Pascal Champéroux, et al.. (2007). Cardiovascular Safety of Gadoterate Meglumine (Gd-DOTA). Investigative Radiology. 42(2). 63–77. 19 indexed citations
4.
Zhou, Honghui, Virginia Parks, Alain Patat, et al.. (2004). Absence of a Clinically Relevant Interaction Between Etanercept and Digoxin. The Journal of Clinical Pharmacology. 44(11). 1244–1251. 24 indexed citations
5.
Spinelli, R., et al.. (1999). Pharmacokinetics (PK) of Aromasin® (exemestane, EXE) after single and repeated doses in healthy postmenopausal volunteers (HPV). European Journal of Cancer. 35. S295–S295. 24 indexed citations
6.
Schück, Stéphane, et al.. (1998). Effect of bromazepam versus placebo on inhibition and waiting capacity in young women with traits of anxiety. Fundamental and Clinical Pharmacology. 12(4). 463–467. 5 indexed citations
7.
Patat, Alain, et al.. (1998). Absolute Bioavailability and Electroencephalographic Effects of Conventional and Extended‐Release Formulations of Venlafaxine in Healthy Subjects. The Journal of Clinical Pharmacology. 38(3). 256–267. 29 indexed citations
8.
Allain, H., et al.. (1998). Use of zolpidem 10 mg as a benzodiazepine substitute in 84 patients with insomnia. Human Psychopharmacology Clinical and Experimental. 13(8). 551–559. 11 indexed citations
9.
Patat, Alain, F. Le Coz, C. Dubruc, et al.. (1996). Pharmacodynamics and Pharmacokinetics of Two Dose Regimens of Befloxatone, a New Reversible and Selective Monoamine Oxidase Inhibitor, at Steady State in Healthy Volunteers. The Journal of Clinical Pharmacology. 36(3). 216–229. 16 indexed citations
10.
Allain, H., Serge Belliard, Alain Lieury, et al.. (1996). [Randomized double-blind comparative study of minaprine (200mg/j) and of placebo on memory loss].. PubMed. 51(2). 155–62. 4 indexed citations
11.
12.
Coz, F. Le, et al.. (1995). Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization*. Clinical Pharmacology & Therapeutics. 57(5). 533–542. 49 indexed citations
13.
Patat, Alain, J.M. Gandon, Geneviève Durrieu, et al.. (1995). Effects of single and multiple doses of a new reversible MAO‐A inhibitor, befloxatone, on psychomotor performance and memory in healthy subjects. Human Psychopharmacology Clinical and Experimental. 10(2). 111–125. 10 indexed citations
14.
Allain, H., et al.. (1994). [The elderly healthy volunteer: a necessity].. PubMed. 48(3). 239–42. 2 indexed citations
15.
Coz, F. Le, et al.. (1992). Prediction of sotalol-induced maximum steady-state QTc prolongation from single-dose administration in healthy volunteers. Clinical Pharmacology & Therapeutics. 52(4). 417–426. 28 indexed citations
16.
Allain, H., et al.. (1992). Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology. 106(S1). S56–S61. 52 indexed citations
17.
Allain, H., et al.. (1992). A DOUBLE BLIND STUDY OF THE EFFECT OF ZOLPIDEM IN CHRONIC INSOMNIAC OUTPATIENTS IN SUBSTITUTION OF TRIAZOLAM.. Clinical Neuropharmacology. 15. 77B–77B. 2 indexed citations
18.
Coz, F. Le, J.‐M. POIRIER, J. L. Cuche, et al.. (1991). Oral Pharmacokinetics of Bisoprolol in Resting and Exercising Healthy Volunteers. Journal of Cardiovascular Pharmacology. 18(1). 28–34. 15 indexed citations
19.
Allain, H., et al.. (1991). Postmarketing Surveillance of Zopiclone in Insomnia: Analysis of 20,513 Cases. SLEEP. 14(5). 408–413. 35 indexed citations
20.
Funck‐Brentano, Christian, et al.. (1991). Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.. Circulation. 83(2). 536–545. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Dubruc Breakdown of academic impact, for papers by O Varoquaux Breakdown of academic impact, for papers by M Maggini Breakdown of academic impact, for papers by Hidenobu Suzuki Breakdown of academic impact, for papers by Taneem Amin Breakdown of academic impact, for papers by Ulrike Ebert Breakdown of academic impact, for papers by Eric Legangneux Breakdown of academic impact, for papers by R E Newton Breakdown of academic impact, for papers by Jill Goddard Breakdown of academic impact, for papers by Michael Desch
Rankless by CCL
2026